-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-26
AGL:NYE- (USD)
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 6.55Change
+0.27 (+4.30)%Market Cap
USD 2.58BVolume
3.91MVerdict
Verdict
Values as of: 2024-06-26
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 6.55Change
+0.27 (+4.30)%Market Cap
USD 2.58BVolume
3.91MVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
HCA | HCA Holdings Inc |
-22.01 (-6.41%) |
USD 89.22B |
THC | Tenet Healthcare Corporation |
-5.27 (-3.81%) |
USD 13.29B |
UHS | Universal Health Services Inc |
-6.63 (-3.46%) |
USD 12.78B |
DVA | DaVita HealthCare Partners Inc |
-2.88 (-2.04%) |
USD 12.08B |
FMS | Fresenius Medical Care Corpora.. |
-0.08 (-0.42%) |
USD 11.24B |
EHC | Encompass Health Corp |
-0.07 (-0.08%) |
USD 8.59B |
CHE | Chemed Corp |
-2.36 (-0.43%) |
USD 8.16B |
ENSG | The Ensign Group Inc |
+2.85 (+2.36%) |
USD 6.90B |
SEM | Select Medical Holdings |
-0.03 (-0.09%) |
USD 4.47B |
AMN | AMN Healthcare Services Inc |
-0.56 (-1.08%) |
USD 2.02B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
MVW:AU | VanEck Vectors Australian.. | 1.55 % | 0.00 % |
+0.15 (+0.42%) |
USD 2.27B |
BTAL | AGFiQ U.S. Market Neutral.. | 0.00 % | 0.00 % |
+0.04 (+0.42%) |
USD 0.23B |
JPIN | JPMorgan Diversified Retu.. | 0.00 % | 0.40 % |
+0.12 (+0.42%) |
USD 0.37B |
MOTI | 0.00 % | 0.57 % |
N/A |
N/A | |
XHS | SPDR® S&P Health Care Se.. | 0.00 % | 0.35 % |
-0.27 (0.42%) |
USD 0.08B |
Market Performance vs. Industry/Classification (Medical Care Facilities) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -47.81% | 5% | F | 2% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -47.81% | 5% | F | 2% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -62.44% | 5% | F | 3% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -62.44% | 5% | F | 3% | F | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | -19.76% | 9% | A- | 4% | F | ||
Dividend Return | -19.76% | 9% | A- | 4% | F | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 28.52% | 64% | D | 37% | F | ||
Risk Adjusted Return | -69.28% | 9% | A- | 5% | F | ||
Market Capitalization | 2.58B | 67% | D+ | 67% | D+ |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The stock is trading high compared to its peers median on a price to book value basis.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
This stock has shown below median revenue growth in the previous 5 years compared to its sector